Letters
Neonatal drug withdrawal
Call for increased pharmacovigilance of gabapentin
BMJ 2017; 359 doi: https://doi.org/10.1136/bmj.j5456 (Published 30 November 2017) Cite this as: BMJ 2017;359:j5456
- Alyssa M Peckham, assistant professor,
- Kathleen A Fairman, adjunct assistant professor,
- David A Sclar, professor and chair
- Department of Pharmacy Practice, College of Pharmacy-Glendale, Midwestern University, 19555 N 59th Avenue, Glendale, AZ 85308, USA
- apeckh{at}midwestern.edu
Huybrechts and colleagues find increased risk of neonatal drug withdrawal when gabapentin and opioids are co-prescribed.1 We conducted the first large scale assessment of the prevalence and clinical consequences of gabapentin misuse.23 The top 1% of gabapentin users consumed or diverted 19% of total gabapentin supply at mean (median) 11 274 (9534) mg/day; nearly 25% of these users exceeded 12 822 mg/day.2 Additionally, 24% …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.